Fei Chen
Impact in
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 1%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- RNA modifications and cancer 10
- Epigenetics and DNA Methylation 9
- RNA Research and Splicing 5
- Renal and related cancers 5
- Oncology 50
- Cancer Cells and Metastasis 11
- Pancreatic and Hepatic Oncology Research 10
- Peptidase Inhibition and Analysis 7
- Cancer-related Molecular Pathways 6
- Co-authors
- Zhen Dong (3 shared papers)Hongjuan Cui (5 shared papers)Gaichao Zhao (1 shared paper)Pengfei Shi (1 shared paper)Jiayi Zhang (1 shared paper)Jie Xu (1 shared paper)Liqun Yang (1 shared paper)Guanghui Zhang (1 shared paper)
- Journals
- Oncotarget (6 papers)Cancer Research (4 papers)Seminars in Cancer Biology (4 papers)Frontiers in Oncology (3 papers)PLoS ONE (3 papers)
- Partner nations
- ChinaUnited StatesSaudi Arabia
In The Last Decade
Fei Chen
88 papers receiving 4.8k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Cancer Research 1.4k
- Oncology 2.1k
- Immunology 1.0k
- Molecular Biology 2.7k
- Cell Biology 295
Countries citing papers authored by Fei Chen
This map shows the geographic impact of Fei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Chen more than expected).
Fields of papers citing papers by Fei Chen
This network shows the impact of papers produced by Fei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Chen. The network helps show where Fei Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 93 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Targeting cancer stem cell pathways for cancer therapy Hit paper breakdown → | 2020 | 1349 |
| 2 | CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness Hit paper breakdown → | 2018 | 921 |
| 3 | A Positive Feedback Loop between Mesenchymal-like Cancer Cells and Macrophages Is Essential to Breast Cancer Metastasis Hit paper breakdown → | 2014 | 609 |
| 4 | 2012 | 169 | |
| 5 | 2019 | 128 | |
| 6 | 1999 | 89 | |
| 7 | 2011 | 88 | |
| 8 | 2021 | 81 | |
| 9 | 2009 | 76 | |
| 10 | 2005 | 62 | |
| 11 | 2019 | 55 | |
| 12 | 2016 | 54 | |
| 13 | 2012 | 53 | |
| 14 | 2013 | 50 | |
| 15 | 2004 | 46 | |
| 16 | 2013 | 42 | |
| 17 | 1999 | 39 | |
| 18 | 2013 | 39 | |
| 19 | 2022 | 38 | |
| 20 | 2019 | 37 |
About Fei Chen
Fei Chen is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Epidemiology, having authored 93 papers that have together received 4.9k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (11 papers), RNA modifications and cancer (10 papers), Pancreatic and Hepatic Oncology Research (10 papers), Epigenetics and DNA Methylation (9 papers), Peptidase Inhibition and Analysis (7 papers), Cancer-related Molecular Pathways (6 papers), RNA Research and Splicing (5 papers) and Renal and related cancers (5 papers). The work is most often cited by research in Cancer Research (1.4k citations), Oncology (2.1k citations), Immunology (1.0k citations), Molecular Biology (2.7k citations) and Cell Biology (295 citations). Fei Chen has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Zhen Dong, Hongjuan Cui, Gaichao Zhao, Pengfei Shi, Jiayi Zhang, Jie Xu, Liqun Yang, Guanghui Zhang, Wen Peng and Xiaowen Wang. Their work appears in journals such as Oncotarget, Cancer Research, Seminars in Cancer Biology, Frontiers in Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.